CEBPA and fatty liver disease: Other studies suggested that inhibition of CDK4 plays an important role in hepatic fatty acid metabolism in reducing CCAAT-enhancer-binding proteins (C/EBPα)/ histone acetyltransferase p300 complexes and eliminating hepatic steatosis [39].